Colorectal cancer screening via smartphone?

App-based early detection is as accurate as laboratory tests and could motivate more people to undergo screening

12-Jun-2025 - Colorectal cancer screening programs are currently underutilized in Germany. This also applies to testing for blood in the stool. The immunological stool tests can detect tiny amounts of blood in the stool. Scientists at the German Cancer Research Center (DKFZ) have investigated whether ...

Predicting cancer risk more precisely

Li-Fraumeni syndrome: A new type of cluster analysis makes customised cancer screening tests possible

18-Mar-2025 - People with the rare Li-Fraumeni syndrome (LFS) have a high risk of developing cancer. Almost all those affected will develop cancer once, and in many cases several times, during their lifetime. LFS is a hereditary disease caused by disease-relevant variants in the TP53 gene. Researchers at ...

Scientists identify cancer biomarkers in breast milk

Proteins could one day allow breast cancer screening to be done with a blood test

07-Apr-2022 - A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers that researchers identified using breast milk. “Although mammograms are a useful tool for catching breast cancer early, they aren’t typically recommended for low-risk ...

Illumina to acquire start-up GRAIL

Launch new era of cancer detection

23-Sep-2020 - Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit percentage ...

Novel test for the earlier detection of multiple cancers

Thrive Launches with $110 Million Series A Financing

19-Jun-2019 - Thrive Earlier Detection Corp., a company dedicated to incorporating earlier cancer detection into routine medical care, launched with $110 million in a Series A financing. Thrive will further advance and commercialize CancerSEEK, a liquid biopsy test designed to detect multiple cancer types at ...

1 in 7 colorectal cancer patients diagnosed before recommended screening age

26-Jan-2016 - Nearly 15 percent of patients diagnosed with colorectal cancer were younger than 50, the age at which screening recommendations begin. The study by researchers at the University of Michigan Comprehensive Cancer Center also found that younger patients were more likely to have advanced disease. The ...

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

15-Apr-2015 - Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood. CAPP ...

New blood test determines whether you have or are likely to get cancer

New research suggests that white blood cells exposed to UVA light in agar, to induce DNA damage, can predict if one has or is at risk for cancer

02-Oct-2014 - A new research report published in the October 2014 issue of The FASEB Journal may make the early detection of cancer as easy as a simple blood test. This test, called the "lymphocyte genome sensitivity" (LGS) test, could not only detect some cancers earlier than ever before, but it may eliminate ...

Oncgnostics GmbH obtains seed funding for financing preclinical and clinical trials

High-Tech Gründerfonds and STIFT invest into molecular cancer diagnostics from Jena

19-Apr-2012 - Chemical alterations of the genetic information specifically occuring during carcinogenesis provide the basis for the innovative diagnostic tests that are developed by the newly established oncgnostics GmbH in Jena. These tests allow not only for an earlier, but also a more accurate detection of ...

Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets

19-Sep-2011 - Abnova Corporation and Clearbridge BioMedics announced a collaboration to jointly develop a platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring. Through this collaboration, Abnova will leverage upon Clearbridge BioMedics’ ...